MedTrace Logo

Validation Study of WITHINGS BPM Core for the Detection of Atrial Fibrillation

NCT04464499 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-02-18

No results posted yet for this study

Summary

The proposed clinical study aims to validate the diagnostic performance, compared to a reference ECG, of the electrocardiographic function of the BPM Core developed by Withings for the automatic identification of atrial fibrillation (AF).

Conditions

Interventions

DIAGNOSTIC_TEST

ECG measurement

Simultaneous recording of a single-lead ECG signal with the Withings BPM Core and ECG signal for the reference 12-lead ECG

Sponsors & Collaborators

  • Withings

    lead INDUSTRY

Principal Investigators

  • David Campo, PhD · Withings

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2021-03-15
Completion
2027-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04464499 on ClinicalTrials.gov